Advertisement

More articles from Spotlight on Clinical Response

  • Intratumoral Molecular Heterogeneity
    James S. Wilmott, Varsha Tembe, Julie R. Howle, Raghwa Sharma, John F. Thompson, Helen Rizos, Roger S. Lo, Richard F. Kefford, Richard A. Scolyer, Georgina V. Long
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2704-2708; DOI: 10.1158/1535-7163.MCT-12-0530
  • Erlotinib Response EGFR+ NSCLC with Squamous Element
    Paul K. Paik, Anna M. Varghese, Camelia S. Sima, Andre L. Moreira, Marc Ladanyi, Mark G. Kris, Natasha Rekhtman
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2535-2540; DOI: 10.1158/1535-7163.MCT-12-0163
  • Chondrosarcoma and TRAIL Targeted Therapy
    Vivek Subbiah, Robert E. Brown, Jamie Buryanek, Jonathan Trent, Avi Ashkenazi, Roy Herbst, Razelle Kurzrock
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2541-2546; DOI: 10.1158/1535-7163.MCT-12-0358
  • Opposing Responses to Endocrine Therapy in Two Breast Tumors
    Justin M. Balko, Ingrid A. Mayer, Melinda E. Sanders, Todd W. Miller, Maria G. Kuba, Ingrid M. Meszoely, Nikhil Wagle, Levi A. Garraway, Carlos L. Arteaga
    Molecular Cancer Therapeutics Oct 2012, 11 (10) 2301-2305; DOI: 10.1158/1535-7163.MCT-12-0511
  • Changes in FDG Uptake as Marker of EGFR Antibody Activity
    Geoffrey W. Krystal, Erin Alesi, James L. Tatum
    Molecular Cancer Therapeutics Jul 2012, 11 (7) 1385-1388; DOI: 10.1158/1535-7163.MCT-12-0011
  • Overcoming Platinum Resistance Using a Copper-Lowering Agent
    Siqing Fu, Aung Naing, Caroline Fu, Macus Tien Kuo, Razelle Kurzrock
    Molecular Cancer Therapeutics Jun 2012, 11 (6) 1221-1225; DOI: 10.1158/1535-7163.MCT-11-0864
  • Personalized Cancer Treatment
    Manuel Hidalgo, Elizabeth Bruckheimer, N.V. Rajeshkumar, Ignacio Garrido-Laguna, Elizabeth De Oliveira, Belen Rubio-Viqueira, Steven Strawn, Michael J. Wick, James Martell, David Sidransky
    Molecular Cancer Therapeutics Aug 2011, 10 (8) 1311-1316; DOI: 10.1158/1535-7163.MCT-11-0233
  • Personalizing Cancer Treatment
    Maria C. Villarroel, N.V. Rajeshkumar, Ignacio Garrido-Laguna, Ana De Jesus-Acosta, Siân Jones, Anirban Maitra, Ralph H. Hruban, James R. Eshleman, Alison Klein, Daniel Laheru, Ross Donehower, Manuel Hidalgo
    Molecular Cancer Therapeutics Jan 2011, 10 (1) 3-8; DOI: 10.1158/1535-7163.MCT-10-0893
  • Treatment of Castleman's Disease with Anakinra
    Hazem El-Osta, Filip Janku, Razelle Kurzrock
    Molecular Cancer Therapeutics Jun 2010, 9 (6) 1485-1488; DOI: 10.1158/1535-7163.MCT-10-0156
  • Paclitaxel, Trastuzumab, and IL-12
    Tanios S. Bekaii-Saab, Julie M. Roda, Kristan D. Guenterberg, Bhuvanaswari Ramaswamy, Donn C. Young, Amy K. Ferketich, Tammy A. Lamb, Michael R. Grever, Charles L. Shapiro, William E. Carson
    Molecular Cancer Therapeutics Nov 2009, 8 (11) 2983-2991; DOI: 10.1158/1535-7163.MCT-09-0820

Pages